Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2000, No. 01
(2000; 18 pages)
Table of Contents
View the documentEditorial
Open this folder and view contentsRegulatory matters
Open this folder and view contentsSafety of medicines
View the documentFeature: Immunization safety: a global priority
View the documentFiller: WHO/UNICEF vaccine quality surveys
View the documentSafety of vaccines: Registration of vaccines
 

WHO Pharmaceuticals Newsletter 2000, No. 01

prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden

No. 1, 2000

The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of "drug information officers" and other sources such as specialized bulletins and journals, as well as partners in WHO. The Newsletter is now being prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring who are providing information on adverse drug reactions. The information is produced in the form of resumes in English, full texts of which may be obtained on request from: Quality Assurance and Safety: Medicines, EDM-HTP, World Health Organization, 1211 Geneva 27, Switzerland

E-mail address: QSM@who.int
Fax: +41 22 791 4730

Extensive information on medicines may be obtained from our Internet site: http://www.who.int/'medicines

Further information on adverse reactions may be obtained from the WHO Collaborating Centre for International Drug Monitoring, Stora Target 3, S-753 20 Uppsala, Sweden

Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet:http://www.who-umc.org

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014